Jones Financial Companies’s Checkpoint Therapeutics CKPT Stock Holding History

Jones Financial Companies’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,332	Closed	-$5.38K	–	4049
2025 Q1	$5.38K	Hold	1,332	–	–	﹤0.01%	2937
2024 Q4	$4.26K	Buy	+1,332	New	+$4.52K	﹤0.01%	2803

Jones Financial Companies's CKPT Position: Q2 2025 in Review

Jones Financial Companies sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,332 shares — an estimated $5.38K sold.

Jones Financial Companies first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $5.38K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Jones Financial Companies reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Jones Financial Companies sold 1,332 Checkpoint Therapeutics shares in Q2 2025, an estimated $5.38K.
Jones Financial Companies first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
Jones Financial Companies's Checkpoint Therapeutics position peaked at $5.38K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Jones Financial Companies's 13F filing for Q2 2025, filed 13 Aug 2025.